These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 203105)

  • 1. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
    Galoian AA; Gurvits BIa; Pogosian MA
    Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of rat heart and brain cyclic adenosine-3',5'-monophosphate phosphodiesterase in vitro under the influence of neurohormone C].
    Galoian AA; Gurvits BIa; Pogosian MA
    Biull Eksp Biol Med; 1977 Jun; 83(6):691-3. PubMed ID: 195650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of neurohormone "C" on adenine nucleotide and adenosine metabolism in rat heart and brain].
    Galoian AA; Guvrits BIa; Galstian RG
    Vopr Biokhim Mozga; 1976; 11():197-207. PubMed ID: 1032220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the inhibition by beta adrenergic receptor agonists of cyclic AMP phosphodiesterase activity of rat heart.
    Ain-Shoka AA; Buckner CK
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):269-78. PubMed ID: 28097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP; Bachner J; Löffler E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of chlorphenesin and divalent metal ions with phosphodiesterase.
    Edelson J; McMullen JP
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):24-33. PubMed ID: 187130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory action of newly synthesized 1,3-dimethylxanthine derivatives on the 3',5'-cyclic AMP phosphodiesterase activity of the homogenates of various tissues].
    Staneva D; Bogoslovova T; Pankova A
    Eksp Med Morfol; 1980; 19(3):154-9. PubMed ID: 6252004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
    Saeed SA; Butt NM; Lovely JR; Collier HO
    Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of nicergoline on reaction kinetics of various forms of cyclic AMP phosphodiesterase.
    Pericin D; Leskovac V
    Arzneimittelforschung; 1981; 31(12):2082-5. PubMed ID: 6277342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of antioxidants of the 3-hydroxypyridine class on cyclic 3', 5'-adenosine monophosphate phosphodiesterase activity].
    Smirnov LD; Malykhina LS; Lazarevich VG; Fedorov NA
    Biull Eksp Biol Med; 1983 Sep; 96(9):40-2. PubMed ID: 6311309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain.
    Stancheva S; Uzunov P; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial effects of flavonoids from Crataegus species.
    Schüssler M; Hölzl J; Fricke U
    Arzneimittelforschung; 1995 Aug; 45(8):842-5. PubMed ID: 7575743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
    Nemoz G; Prigent AF; Pacheco H
    Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
    Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
    Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition by 2- or/and 8-substituted adenosine derivatives of adenosine deaminase and calmodulin-dependent phosphodiesterase.
    Sasaki Y; Ono Y
    Nucleic Acids Symp Ser; 1980; (8):s163-6. PubMed ID: 6265879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone inhibits purified taste bud membrane adenosine 3',5'-monophosphate phosphodiesterase activity.
    Law JS; Henkin RI
    Res Commun Chem Pathol Pharmacol; 1984 Mar; 43(3):449-62. PubMed ID: 6326212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.